AVII77 “The DCVax trial randomized 331 out of 962 GBM patients they considered. The majority of those excluded were for the reason of disease progression. “ https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6/figures/1 Not to sure about your claim. Just saw you’re comments on this. But still yet only 250 excluded due to progression. Not sure that would be “most”. Roughly 1 out of 5.
Market Data 
Markets 
AI
